A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

被引:727
作者
Hoster, Eva [1 ]
Dreyling, Martin [1 ,2 ]
Klapper, Wolfram [3 ]
Gisselbrecht, Christian [4 ]
van Hoof, Achiel [5 ]
Kluin-Nelemans, Hanneke C. [6 ]
Pfreundschuh, Michael [7 ]
Reiser, Marcel [8 ]
Metzner, Bernd [9 ]
Einsele, Hermann [10 ]
Peter, Norma [11 ]
Jung, Wolfram [12 ]
Woermann, Bernhard [13 ]
Ludwig, Wolf-Dieter [14 ]
Duehrsen, Ulrich [15 ]
Eimermacher, Hartmut [16 ]
Wandt, Hannes [17 ]
Hasford, Joerg [2 ]
Hiddemann, Wolfgang [1 ]
Unterhalt, Michael [1 ]
机构
[1] Univ Munich, Klinikum Grosshadern, Med Klin 3, Dept Internal Med 3, D-81377 Munich, Germany
[2] Univ Munich, Dept Med Informat Biometry & Epidemiol, D-81377 Munich, Germany
[3] Univ Kiel, Inst Pathol, Lymph Node Registry, D-2300 Kiel, Germany
[4] Hop St Louis, Dept Hematol, Paris, France
[5] Akad Ziekenhuis St Jan, Dept Hematol, Brugge, Belgium
[6] Univ Groningen, Med Ctr, Dept Hematol, Groningen, Netherlands
[7] Univ Saarland, Sch Med, Dept Internal Med, D-6650 Homburg, Germany
[8] Univ Cologne, Dept Internal Med 1, Cologne, Germany
[9] Klin Oldenburg, Dept Hematol & Oncol, Oldenburg, Germany
[10] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany
[11] Carl Thiem Hosp, Dept Hematol Oncol, Cottbus, Germany
[12] Univ Gottingen, Dept Hematol & Oncol, Gottingen, Germany
[13] Klinikum Stadt Braunschweig, Braunschweig, Germany
[14] HELIOS Klin, Dept Hematol & Oncol, Berlin, Germany
[15] Univ Hosp Essen, Dept Hematol, Essen, Germany
[16] Kathol Krankenhaus Hagen, Dept Hematol & Oncol, Hagen, Germany
[17] Klinikum Nurnberg Nord, Med Dept 5, Nurnberg, Germany
关键词
D O I
10.1182/blood-2007-06-095331
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is no generally established prognostic index for patients with mantle cell lymphoma (MCL), because the International Prognostic Index (IPI) and Follicular Lymphoma International Prognostic Index (FLIPI) have been developed for diffuse large cell and follicular lymphoma patients, respectively. Using data of 455 advanced stage MCL patients treated within 3 clinical trials, we examined the prognostic relevance of IPI and FLIPI and derived a new prognostic index (MCL international prognostic index, MIPI) of overall survival (OS). Statistical methods included Kaplan-Meier estimates and the log-rank test for evaluating IPI and FLIPI and multiple Cox regression for developing the MIPI. IPI and FLIPI showed poor separation of survival curves. According to the MIPI, patients were classified into low risk (44% of patients, median OS not reached), intermediate risk (35%, 51 months), and high risk groups (21%, 29 months), based on the 4 independent prognostic factors: age, performance status, lactate dehydrogenase (LDH), and leukocyte count. Cell proliferation (Ki-67) was exploratively analyzed as an important biologic marker and showed strong additional prognostic relevance. The MIPI is the first prognostic index particularly suited for MCL patients and may serve as an important tool to facilitate risk-adapted treatment decisions in patients with advanced stage MCL.
引用
收藏
页码:558 / 565
页数:8
相关论文
共 39 条
[1]   DANGERS OF USING OPTIMAL CUTPOINTS IN THE EVALUATION OF PROGNOSTIC FACTORS [J].
ALTMAN, DG ;
LAUSEN, B ;
SAUERBREI, W ;
SCHUMACHER, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (11) :829-835
[2]   Systematic reviews in health care - Systematic reviews of evaluations of prognostic variables [J].
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7306) :224-228
[3]   A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors [J].
Andersen, NS ;
Jensen, MK ;
Brown, PD ;
Geisler, CH .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (03) :401-408
[4]  
[Anonymous], 1994, INTRO BOOTSTRAP
[5]   Mantle cell lymphoma: A clinicopathologic study of 80 cases [J].
Argatoff, LH ;
Connors, JM ;
Klasa, RJ ;
Horsman, DE ;
Gascoyne, RD .
BLOOD, 1997, 89 (06) :2067-2078
[6]   MANTLE CELL LYMPHOMA - A PROPOSAL FOR UNIFICATION OF MORPHOLOGICAL, IMMUNOLOGICAL, AND MOLECULAR-DATA [J].
BANKS, PM ;
CHAN, J ;
CLEARY, ML ;
DELSOL, G ;
DEWOLFPEETERS, C ;
GATTER, K ;
GROGAN, TM ;
HARRIS, NL ;
ISAACSON, PG ;
JAFFE, ES ;
MASON, D ;
PILERI, S ;
RALFKIAER, E ;
STEIN, H ;
WARNKE, RA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (07) :637-640
[7]  
Bosch F, 1998, CANCER, V82, P567, DOI 10.1002/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO
[8]  
2-Z
[9]  
Chan WC, 1997, BLOOD, V89, P3909